There appears to be a remarkable consensus 
cost will be the overriding consideration. We are spending more than $800 billion annually for health care, which represents 14% of the Gross National Product, up from 9.1% in 1981. This is three times the amount spent on defense and twice that spent on education (1 Medicare, replaced retrospective itemized payment for inpatient hospital services with a prospective system in which a comprehensive payment is made to the hospital according to the patient's diagnosis-the Diagnosis-Related Group (DRG). It is important to note that introduction of the flat payment, which does not identify charges for laboratory services, immediately converted the clinical laboratory from a revenue center to a cost center for these patients. We should anticipate similar comprehensive payments for most or all patients, both inpatients and outpatients, and from all insurance carriers. As can be seen from the data in the article by Benge et al., introduction of DRGs had no effect on test utilization. It also had no effect on utilization of other hospital services. Hospitals coped with these unwelcome financial constraints by raising their charges for all services, to collect as much as possible from the charge-based insurance carriers, private insurance companies that will pay what is charged and that can recoup the expenditures by raising premiums paid by the policy holders. As indicated in the article, this practice is called "cost shifting."
A number of interrelated problems must be addressed in any health care reform program. Recent experience has demonstrated that simply increasing the amount of money being poured into the system is not a viable solution. The major players, government and industry, pay 80% of health care costs, and their immutable objective will be to ensure more prudent, even parsimomous, utilization of medical resources. Monetary constraints will be utilized extensively for this purpose; however, the most effective approach will be to place responsibility for paying a meaningful portion of the total cost of care on the patient, to stimulate cost-conscious consumerism.
By reducing or eliminpting the tax deductions related to employee health insurance, the government will force industry to eramine competing sources of health insurance. The documented but inexplicable differences in utilization of health care resources between physicians in different geographic Fee schedules will be standardized among all insurance carriers to prevent cost shifting, and the >1500 claims forms now in use will be reduced to one standard format-which will be electronic.
Perceived fraud and abuse will be prosecuted vigorously with severe, even draconian, penalties.
Tort reform to reduce the exorbitant costs of malpractice insurance will be an important part of any efforts aimed at cost containment.
And some way will be found to provide basic health insurance for the 37 million Americans who now lack this safety net. There is a macabre surgical aphorism, "Bleeding always stops"; its counterpart in economics must be, "Financial distortions are always corrected" (4) .
What should we in the clinical laboratory do to meet the impending fiscal challenges? We must make wise decisions, and this will require development of management systems that provide the information necessary to select the most cost-effective methods and schedules for providing essential laboratory services. The other side of the coin is that we must identify and eliminate nonessential services. The changes now taking place in the clinical laboratory will require more sophisticated approaches to laboratory management; however, it is essential that we maintain and continue to develop the science and technology that provide the foundation for our contributions to patient care. Failure to do so would result in an optimally managed but obsolete dinosaur.
